Sign In
Buy NEXN
Nexxen International Earnings Calls
| Release date | Nov 21, 2025 |
| EPS estimate | $0.220 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 8.72% |
| Release date | Aug 13, 2025 |
| EPS estimate | $0.190 |
| EPS actual | $0.290 |
| EPS Surprise | 52.63% |
| Revenue estimate | 94.801M |
| Revenue actual | 90.948M |
| Revenue Surprise | -4.06% |
| Release date | May 14, 2025 |
| EPS estimate | $0.0600 |
| EPS actual | $0.160 |
| EPS Surprise | 166.67% |
| Revenue estimate | 87.609M |
| Revenue actual | 78.33M |
| Revenue Surprise | -10.59% |
| Release date | Mar 05, 2025 |
| EPS estimate | $0.320 |
| EPS actual | $0.480 |
| EPS Surprise | 50.00% |
| Revenue estimate | 75.667M |
| Revenue actual | 112.284M |
| Revenue Surprise | 48.39% |
Last 4 Quarters for Nexxen International
Below you can see how NEXN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 05, 2025 |
| Price on release | $9.50 |
| EPS estimate | $0.320 |
| EPS actual | $0.480 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| Feb 27, 2025 | $8.30 |
| Feb 28, 2025 | $8.15 |
| Mar 03, 2025 | $7.40 |
| Mar 04, 2025 | $7.42 |
| Mar 05, 2025 | $9.50 |
| Mar 06, 2025 | $9.02 |
| Mar 07, 2025 | $8.78 |
| Mar 10, 2025 | $8.22 |
| Mar 11, 2025 | $8.23 |
| 4 days before | 14.46% |
| 4 days after | -13.37% |
| On release day | -5.05% |
| Change in period | -0.84% |
| Release date | May 14, 2025 |
| Price on release | $11.62 |
| EPS estimate | $0.0600 |
| EPS actual | $0.160 |
| EPS surprise | 166.67% |
| Date | Price |
|---|---|
| May 08, 2025 | $11.18 |
| May 09, 2025 | $11.54 |
| May 12, 2025 | $11.81 |
| May 13, 2025 | $12.32 |
| May 14, 2025 | $11.62 |
| May 15, 2025 | $11.60 |
| May 16, 2025 | $11.21 |
| May 19, 2025 | $11.19 |
| May 20, 2025 | $11.49 |
| 4 days before | 3.94% |
| 4 days after | -1.12% |
| On release day | -0.172% |
| Change in period | 2.77% |
| Release date | Aug 13, 2025 |
| Price on release | $9.90 |
| EPS estimate | $0.190 |
| EPS actual | $0.290 |
| EPS surprise | 52.63% |
| Date | Price |
|---|---|
| Aug 07, 2025 | $9.90 |
| Aug 08, 2025 | $9.65 |
| Aug 11, 2025 | $9.19 |
| Aug 12, 2025 | $9.74 |
| Aug 13, 2025 | $9.90 |
| Aug 14, 2025 | $9.33 |
| Aug 15, 2025 | $9.55 |
| Aug 18, 2025 | $9.63 |
| Aug 19, 2025 | $9.23 |
| 4 days before | 0% |
| 4 days after | -6.77% |
| On release day | -5.76% |
| Change in period | -6.77% |
| Release date | Nov 21, 2025 |
| Price on release | - |
| EPS estimate | $0.220 |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $7.79 |
| Nov 12, 2025 | $8.04 |
| Nov 13, 2025 | $6.33 |
| Nov 14, 2025 | $6.43 |
| Nov 17, 2025 | $6.49 |
Nexxen International Earnings Call Transcript Summary of Q2 2025
Nexxen reported a solid Q2 with several record metrics and reiterated full‑year 2025 guidance. Contribution ex‑TAC reached a Q2 record of $87.8M (up 6% YoY), programmatic revenue was a Q2 record at $85M (up 8% YoY), and adjusted EBITDA beat expectations at $29.9M (up 12% YoY) with a 34% margin on contribution ex‑TAC. The company has $131.5M cash, no long‑term debt, $50M undrawn on its revolver, and repurchased ~$39.1M of shares in the quarter; the Board is evaluating a new buyback after the current program ends. Management emphasized strategic investment in CTV via an expanded VIDAA partnership (including an additional $35M investment and extended ACR/data exclusivity) that should drive monetization beginning in 2026, and growing tech & data licensing revenue and AI product adoption (nexAI) as key multi‑year growth drivers. Near‑term headwinds include macro uncertainty, tariffs affecting some partners, and modest CTV growth in Q2, but leadership expects continued margin expansion, further efficiency from AI, targeted M&A opportunistically, and potential upside if remedies in the Google antitrust case open additional inventory — although that is not assumed in guidance.
